CODEINE CONTIN 50MG CONTROLLED RELEASE TAB
CODEINE CONTIN 50MG CONTROLLED RELEASE TAB
Approved
DIN Number
02230302
Drug Class
Human
Market Date
Mar 13, 1997
Company
HC
purdue pharma
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02230302
AIG Number0153086003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Narcotic (CDSA I)
A
ATC Code
R05DA04 CODEINE
Product Specifications
Dosage FormTablet (Extended-Release)
Route of AdministrationOral
AHFS Classification28:08.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
CODEINE (CODEINE MONOHYDRATE, CODEINE SULFATE TRIHYDRATE)Active
Strength: 50 MG
Monograph: CODEINE (CODEINE MONOHYDRATE, CODEINE SULFATE TRIHYDRATE)